Method for treating T-cell lymphoblastic leukemia with ara-G nucleoside derivatives
AssigneeBurroughs Wellcome Co. (141)
InventorsThomas A. Krenitsky, Devron R. Averett, George W. Koszalka, Gerald Wolberg
Life of this patent
Estimating the term…
Abstract
6-Alkoxy derivatives of Ara-G, and pharmaceutically acceptable esters thereof, are described as being useful in tumor therapy. Novel pharmaceutically acceptable esters, their preparation and pharmaceutical formulations containing them are also disclosed.
Claims4
A method of treating T-cell lymphoblastic leukemia in a mammal having T-cell lymphoblastic leukemia which comprises administering to said mammal an effective T-cell lymphoblastic leukemia treatment amount of the compound 9-.beta.-D-arabinofuranosyl-2-amino-6-methoxy-9H-purine.
A method of treating T-cell lymphoblastic leukemia in a mammal having T-cell lymphoblastic leukemia which comprises administering to said mammal an effective leukemia treatment amount of the compound 9-.beta.-D-arabinofuranosyl-2-amino-6-methoxy-9H-purine or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.